INBX
Inhibrx Biosciences Inc.
Company Overview
| Mkt Cap | $399.80M | Price | $81.66 |
| Volume | 481.26K | Change | +4.01% |
| P/E Ratio | 0.2 | Open | $77.99 |
| Revenue | $200.0K | Prev Close | $78.51 |
| Net Income | $1.7B | 52W Range | $10.81 - $83.95 |
| Div Yield | N/A | Target | $12.00 |
| Overall | 65 | Value | 70 |
| Quality | 42 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyInhibrx Biosciences Inc. (INBX) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $81.66 with a market capitalization of $399.80 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows INBX with a volume of 481K shares. The stock opened down 0.66% from yesterday's close of $78.51. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
INBX demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for INBX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -85.3%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INBX | $81.66 | +4.0% | 481.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inhibrx Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW